Miral, Genilyn C.
HRN: 28-13-26 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
CEFTRIAXONE 1G (VIAL)
11/18/2025
11/24/2025
IV
2g
OD
CAP-MR
Waiting Final Action
11/18/2025
AZITHROMYCIN 500MG TABLET (TAB)
11/18/2025
11/22/2025
PO
500 Mg
OD
CAP-MR
Waiting Final Action
11/23/2025
MUPIROCIN 2%, 15G (TUBE)
11/23/2025
11/30/2025
TOPICAL
To Area
BID
Infected Wound
Checking Initial Appropriateness